Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: effects on platelet function and cellular adenosine uptake

Ticagrelor is an antagonist of both platelet adenosine diphosphate (ADP) receptor P2Y12 and equilibrative nucleoside transporter-1. Optimal timing of ticagrelor cessation prior to coronary artery bypass grafting (CABG) remains unclear. We characterized the offset of ticagrelor’s effects on platelets...

Descripció completa

Dades bibliogràfiques

Autors principals:	Kok Weng Ow, William A.E. Parker, Mark M. Porter, Jessica Hanson, Heather M. Judge, Norman P. Briffa, Mark R. Thomas, Robert F. Storey
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2020-10-01
Col·lecció:	Platelets
Matèries:	acute coronary syndrome adenosine coronary artery bypass graft surgery platelets ticagrelor
Accés en línia:	http://dx.doi.org/10.1080/09537104.2019.1709631
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!